PReMA and Thai Atherosclerosis Society together with the public and private sector launch “Network Services of Cardiovascular Development Program”

The Pharmaceutical Research & Manufacturers Association (PReMA), in collaboration with Thai Atherosclerosis Society, and supporters from the government as well as the private sector recently held the opening ceremony to launch Network Services of Cardiovascular Development Program.  The aim of this Program is to improve the overall abilities of healthcare professionals in hospitals, so as to reduce the rate of cardiovascular disease, and its impact on mortality in Thailand, therefore resulting in better quality of life for the Thai public.

Photo shows:  AVM. Dr. Banhan Kor-Anuntakul (front row, second from left), founder of the program and former president of Thai Atherosclerosis Society, Dr.Chadsri Phajuabmo (front row, third from left), President of Service Development Board of Cardiology, Ministry of Public Health, Mr.Somchai Nijpanich, Deputy Permanent Secretary, Ministry of Public Health, Dr.Jitti Kositchaiwat, President of the program and Dr.Kitima Yuthavong, CEO, Pharmaceutical Research & Manufacturers Association (PReMA) among chiefs of Cardiac Center and supporters from public sectors including PReMA’s members such as  AstraZeneca (Thailand) Ltd., Boehringer Ingelheim (Thai) Ltd., Pfizer (Thailand) Ltd. and  Takeda (Thailand) Ltd. at the opening ceremony.

 

For media information, please contact:

Total Quality PR (TQPR) Thailand Co. Ltd.,

Maetavarin Maneekulpan/ Tantida Tammakhupat

Tel: 02-260-5820 ext. 115/ 120